Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 151–165 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4099 IGBP1 Gene Genetic Test for Corpus Callosum Agenesis Syndrome This test evaluates the IGBP1 gene for variants associated with corpus callosum agenesis syndrome.	Blood, DNA FTA Card, Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IGBP1 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number alterations"] Parameters [] Preparation [] Indications ["Suspected IGBP1-related disorder", "Diagnosis of corpus callosum agenesis syndrome", "Family counselling for genetic risk"] Measurement technique Confirm with laboratory Codes LOINC: 81304-9 ICD-10: Q04.0, Q87.8 Clinical summary This test evaluates the IGBP1 gene for variants associated with corpus callosum agenesis syndrome.
TEST-2802 IGF1 Gene NGS Testing for Growth Retardation, Deafness, and Intellectual Disability due to IGF1 Deficiency Test This test identifies pathogenic variants in the IGF1 gene associated with a syndrome of severe growth failure, deafness, and intellectual disability.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card finger-prick sample	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IGF1 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusion or active infection"] Indications ["Suspected IGF1 deficiency syndrome", "Severe short stature with hearing loss and developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E34.3 Clinical summary This test identifies pathogenic variants in the IGF1 gene associated with a syndrome of severe growth failure, deafness, and intellectual disability.
TEST-4871 IL2RA Gene Interleukin-2 Receptor Deficiency Genetic Test This genetic test identifies pathogenic mutations within the IL2RA gene, which are associated with CD25 deficiency and severe combined immunodeficiency (SCID).	Whole Blood (EDTA), Extracted DNA, or FTA Card Bloodspot	3–4 weeks (21–28 business days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the IL2RA gene", "Copy Number Variants (CNVs) within IL2RA", "Deep intronic mutations within IL2RA"] Parameters [] Preparation ["No specific fasting required", "No specific medication or diet restrictions"] Indications ["Suspected Severe Combined Immunodeficiency (SCID)", "Evaluation of autoimmune skin disorders", "Investigation of bone abnormalities", "Family history of IL2RA-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21666-1 ICD-10: D81.4 Clinical summary This genetic test identifies pathogenic mutations within the IL2RA gene, which are associated with CD25 deficiency and severe combined immunodeficiency (SCID).
TEST-5384 IL31RA Gene Amyloidosis, Primary Localized Cutaneous, Type 2 Genetic Test This test identifies pathogenic variants in the IL31RA gene associated with Primary Localized Cutaneous Amyloidosis type 2.	Peripheral whole blood or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IL31RA gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of Primary Localized Cutaneous Amyloidosis type 2", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81320-4 ICD-10: E85.4 Clinical summary This test identifies pathogenic variants in the IL31RA gene associated with Primary Localized Cutaneous Amyloidosis type 2.
TEST-3848 INHBA Gene FSH Releasing Protein Deficiency Genetic Test This test evaluates the INHBA gene for variants associated with FSH releasing protein deficiency, a cause of congenital hypogonadotropic hypogonadism.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the INHBA gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNV)"] Parameters [] Preparation ["No fasting required.", "Bring all previous hormone reports, imaging studies, and prior genetic test results."] Indications ["Congenital hypogonadotropic hypogonadism", "Unexplained low FSH/LH levels", "Delayed puberty", "Infertility", "Family history of reproductive disorders"] Measurement technique Confirm with laboratory Codes LOINC: 92822-6 ICD-10: E23.0 Clinical summary This test evaluates the INHBA gene for variants associated with FSH releasing protein deficiency, a cause of congenital hypogonadotropic hypogonadism.
TEST-4746 INPPL1 Gene Opsismodysplasia Genetic Test This test analyzes the INPPL1 gene for mutations associated with Opsismodysplasia, a rare genetic disorder.	Peripheral whole blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the INPPL1 gene"] Parameters [] Preparation ["No special preparation required.", "Mandatory pre-test genetic counselling session."] Indications ["Suspected Opsismodysplasia", "Carrier screening for known family mutations", "Paediatric patients with suspected skeletal dysplasia and dermatologic features"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q78.8 Clinical summary This test analyzes the INPPL1 gene for mutations associated with Opsismodysplasia, a rare genetic disorder.
TEST-4005 JAM3 Gene Hemorrhagic Brain Destruction, Subependymal Calcification & Cataracts (JAM3) Genetic Test This genetic test identifies pathogenic variants in the JAM3 gene associated with a severe syndrome characterized by brain hemorrhage, calcification, and cataracts.	Whole Blood (3-5 mL) or FTA Card (Dried Blood Spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the JAM3 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation [] Indications ["Infants or children with unexplained neonatal brain hemorrhage", "Infants or children with intracranial calcifications", "Infants or children with congenital cataracts", "Carrier testing for families with a history of the condition", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-8 ICD-10: Q04.8, Q12.0 Clinical summary This genetic test identifies pathogenic variants in the JAM3 gene associated with a severe syndrome characterized by brain hemorrhage, calcification, and cataracts.
TEST-2246 KCNH1 Gene Temple-Baraitser Syndrome Genetic Test This test evaluates the KCNH1 gene for pathogenic variants associated with Temple-Baraitser syndrome.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNH1 gene", "Full exon coverage of KCNH1"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications, especially antiepileptics"] Indications ["Suspected Temple-Baraitser syndrome based on clinical features", "Confirmation of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q87.89 Clinical summary This test evaluates the KCNH1 gene for pathogenic variants associated with Temple-Baraitser syndrome.
TEST-4432 KCNT1 Gene Epilepsy (Nocturnal Frontal Lobe) Genetic Test This genetic test evaluates the KCNT1 gene for variants associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) and related epileptic encephalopathies.	Peripheral whole blood, saliva, or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in KCNT1 gene", "Small insertions/deletions in KCNT1 gene", "Copy number changes in KCNT1 gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions unless advised by physician"] Indications ["Suspected Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)", "Diagnosis of related epileptic encephalopathies", "Genetic counseling for families with KCNT1-related epilepsy"] Measurement technique Confirm with laboratory Codes LOINC: 92747-3 ICD-10: G40.0 Clinical summary This genetic test evaluates the KCNT1 gene for variants associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) and related epileptic encephalopathies.
TEST-4894 KDM5C Gene Sequencing (Claes-Jensen Syndrome) DNA Test This test analyzes the KDM5C gene to identify pathogenic variants associated with Claes-Jensen syndrome (X-linked intellectual disability).	Peripheral whole blood (EDTA) or FTA card finger-prick	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KDM5C gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected Claes-Jensen syndrome", "X-linked intellectual disability", "Developmental delay with dysmorphic features"] Measurement technique Confirm with laboratory Codes LOINC: 83934-6 ICD-10: Q87.8 Clinical summary This test analyzes the KDM5C gene to identify pathogenic variants associated with Claes-Jensen syndrome (X-linked intellectual disability).
TEST-3789 KEAP1 Gene Goitre, Multinodular Genetic Test This test evaluates the KEAP1 gene for pathogenic germline variants associated with familial nontoxic multinodular goiter (MNG). It identifies genetic risk factors for MNG and rela...	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic germline variants in the KEAP1 gene", "Single nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "No specific fasting or medication adjustments required unless advised by physician"] Indications ["Patients with a family history of nontoxic multinodular goiter", "Genetic risk stratification for MNG", "Personalised clinical management for MNG"] Measurement technique Confirm with laboratory Codes LOINC: 101351-3 ICD-10: E04.2, Z13.29 Clinical summary This test evaluates the KEAP1 gene for pathogenic germline variants associated with familial nontoxic multinodular goiter (MNG). It identifies genetic risk factors for MNG and related endocrine disorders.
TEST-4594 KIF1A Gene (HSN2C) Genetic Test This test identifies pathogenic variants in the KIF1A gene, which are associated with hereditary sensory neuropathy type 2C (HSN2C), hereditary spastic paraplegia, and early-onset...	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KIF1A gene sequence", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Pedigree charting is mandatory"] Indications ["Diagnosis of hereditary sensory neuropathy type 2C (HSN2C)", "Diagnosis of hereditary spastic paraplegia", "Diagnosis of other KIF1A-related neurological disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94086-1 ICD-10: G60.8 Clinical summary This test identifies pathogenic variants in the KIF1A gene, which are associated with hereditary sensory neuropathy type 2C (HSN2C), hereditary spastic paraplegia, and early-onset neurodegenerative conditions.
TEST-4008 KIF1B Gene CMT2A1 Next-Generation Sequencing Genetic Test This genetic test identifies pathogenic variants within the KIF1B gene associated with autosomal dominant Charcot-Marie-Tooth disease type 2A1.	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KIF1B gene", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed unless advised by physician"] Indications ["Suspected diagnosis of CMT2A1 based on clinical presentation", "Family history of CMT2A1", "Need for definitive molecular confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 82789-9 ICD-10: G60.0 Clinical summary This genetic test identifies pathogenic variants within the KIF1B gene associated with autosomal dominant Charcot-Marie-Tooth disease type 2A1.
TEST-3648 KIF21A Gene Fibrosis of Extraocular Muscles, Congenital Type 1 Genetic Test This test identifies pathogenic variants in the KIF21A gene associated with Congenital Fibrosis of Extraocular Muscles Type 1 (CFEOM1).	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in KIF21A gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number alterations"] Parameters [] Preparation ["No specific fasting required", "Do not alter or discontinue prescribed medications without consulting the treating physician"] Indications ["Suspected diagnosis of Congenital Fibrosis of Extraocular Muscles Type 1 (CFEOM1)", "Family history of CFEOM1", "Need for definitive genetic diagnosis for surgical planning", "Genetic counselling for recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94122-4 ICD-10: H49.81 Clinical summary This test identifies pathogenic variants in the KIF21A gene associated with Congenital Fibrosis of Extraocular Muscles Type 1 (CFEOM1).
TEST-4160 KMT2C Gene Developmental Delay (Kleefstra Syndrome 2) NGS Test This diagnostic test evaluates the KMT2C gene for pathogenic variants associated with Kleefstra syndrome 2.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KMT2C gene", "Coverage of all exons and exon-intron boundaries"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any relevant medications."] Indications ["Suspected Kleefstra syndrome 2 based on clinical presentation", "Developmental delay or intellectual disability of unknown cause", "Family history of Kleefstra syndrome 2"] Measurement technique Confirm with laboratory Codes LOINC: 101155-1 ICD-10: Q93.5 Clinical summary This diagnostic test evaluates the KMT2C gene for pathogenic variants associated with Kleefstra syndrome 2.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.